Device Orthopedic Surgery

Linvatec Shoulder Arthroscopy

Payments companies reported to CMS as associated with Linvatec Shoulder Arthroscopy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$381Kassociated payments (2023-2025)
218clinicians with associated payments
1company reporting

By year

2023 $91K
2024 $8,483
2025 $281K

Payments reported as associated with Linvatec Shoulder Arthroscopy, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Sports Medicine (Orthopaedic Surgery) $333K
Orthopaedic Surgery $44K
Hand Surgery $1,018
Physician Assistant $566
Podiatrist $444
Orthopaedic Surgery of The Spine $389

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Linvatec Shoulder Arthroscopy

These are the largest totals companies reported as associated with Linvatec Shoulder Arthroscopy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Felix Savoie New Orleans, LA Sports Medicine (Orthopaedic Surgery) $246,961.73
Stephen Snyder Van Nuys, CA Sports Medicine (Orthopaedic Surgery) $51,459.87
Nathan Skelley Sioux Falls, SD Orthopaedic Surgery $19,050.15
Bart Eastwood Blacksburg, VA Sports Medicine (Orthopaedic Surgery) $12,813.61
Kris Abeln New Albany, IN Orthopaedic Surgery $8,112.64
Jeffrey Abrams Princeton, NJ Orthopaedic Surgery $4,354.73
Michael Freehill Stanford, CA Sports Medicine (Orthopaedic Surgery) $3,681.46
Alan Zhang San Francisco, CA Sports Medicine (Orthopaedic Surgery) $3,077.85
Thomas Gill Dedham, MA Sports Medicine (Orthopaedic Surgery) $2,831.91
Stephan Pill Greenville, SC Sports Medicine (Orthopaedic Surgery) $2,715.05

Prescribed Linvatec Shoulder Arthroscopy?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.